Company intelligence / Profile preview

Biokart India

Bangalore, Karnataka, Indiabiokart.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Biokart India is an active genomics service provider offering comprehensive molecular testing, nucleic acid extraction, Sanger sequencing, next-generation sequencing (NGS), and bioinformatics solutions to researchers across government institutes, diagnostic labs, biopharma companies, and biotech R&D centers. The company has played roles in public health initiatives such as COVID-19 genome sequencing programs.

Industry: Drug Discovery Services

Partnerships

Participated with Indira Gandhi Institute of Medical Sciences for COVID-19 genome sequencing program

Beyond the preview

Go deeper on Biokart India.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biokart India.

Explore the full profile